View Author
patient stent trial disease study event death group point stent thrombosis lesion heart thrombosis hospital outcome angioplasty treatment artery follow-up end points mortality infarction registry revascularization result therapy procedure definition randomized artery disease university table safety polyvascular end point cardiol abciximab angiographic vessel factor circulation intervention polyvascular disease hospitalization balloon drug-eluting polyvascular disease patients risk factors analysis balloon angioplasty group placebo baseline month device stenting stroke restenosi stent group drug-eluting stents lp-pla 2 activity angina aneurysm ef ficacy target balloon angioplasty failure implantation research rotterdam number aortic committee effect 30 days solid-timi 52 trial bene fit survival investigator lp-pla darapladib
10 Most Recent Publications
|
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome
(Article)
O'Donoghue, M.L. Braunwald, E. Cicconetti, G. Lukas, M.A. Tarka, E. Cannon, C.P. White, H.D. Serruys, P.W.J.C. Steg, P.G. Hochman, J.S. Maggioni, A.P. Bode, C. Weaver, W.D. Johnson, J.L. |
2011-10-01
|
|
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH registry
(Article)
Suárez, C. Zeymer, U. Limbourg, T. Baumgartner, I. Cacoub, P.P. Poldermans, D. Röther, J. Bhatt, D.L. Steg, P.G. |
2010-08-01
|
|
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation
(Article)
Camenzind, E. Wijns, W. O'Neill, W.W. Serruys, P.W.J.C. Jorissen, B. Steg, P.G. Mauri, L. Boersma, H. Parikh, K. Kurowski, V. Gao, R. Bode, C. Greenwood, J.P. Gershlick, A. |
2009-12-01
|
|
Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?
(Article)
Cohn, J. Cleland, J.G.F. Lubsen, J. Borer, J.S. Steg, P.G. Perelman, M. Zannad, F. |
2009-04-01
|
|
Meeting report: ESC forum on drug eluting stents European heart house, Nice, 27-28 September 2007
(Article)
Daemen, J. Simoons, M.L. Fajadet, J. Gitt, A.K. Guagliumi, G. Hillege, H.L. James, S.K. Jùni, P. Kastrati, A. Kloth, S. Kristensen, S.D. Krucoff, M. Wijns, W. Legrand, V.M.G. Pfisterer, M.E. Rothman, M. Serruys, P.W.J.C. Silber, S. Steg, P.G. Tariah, I. Wallentin, L.C. Windecker, S. Aimonetti, A. Bagust, A. Allocco, D. Baczynska, A. Berenger, M. Boam, A. Calle, J.P. Campo, G. Carlier, S.G. Schepper, J. de Bisceglie, G. di Dobbels, H. Bos, G. Farb, A. Ghislain, J.C. Hellbardt, S. Hoedt, R. ten Isaia, C. Jong, P. de Klasen, E. Lekehal, M. LeNarz, L. Ni Mhullain, F. Bowen, J.M. Nagai, H. Patteet, A. Paunovic, D. Potgieter, A. Purdy, I. Raveau-Landon, C. Ternstrom, S. Wuytswinkel, J. van Waliszewski, M. Braunwald, E. Camenzind, E. Chevalier, B. DiMario, C. |
2009-01-01
|
|
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry
(Article)
Baumgartner, I. Hirsch, A.T. Abola, M.T.B. Cacoub, P.P. Poldermans, D. Steg, P.G. Creager, M.A. Bhatt, D.L. |
2008-10-01
|
|
Clinical end points in coronary stent trials: A case for standardized definitions
(Article)
Cutlip, D.E. Windecker, S. McFadden, E.P. Lansky, A.J. Hamon, M. Krucoff, M. Serruys, P.W.J.C. Mehran, R. Boam, A. Cohen, D.J. Es, G.A. van Steg, P.G. Morel, M-A.M. Mauri, L. Vranckx, P. |
2007-05-01
|
|
A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators.
(Article)
Maillard, L. Hamon, M. Brunel, P. Grollier, G. Koning, R. Coste, P. Favereau, X. Lancelin, B. Belle, E. van Serruys, P.W.J.C. Monassier, J-P. Raynaud, P. Khalife, K. Steg, P.G. Beygui, F. Guermonprez, J-L. Spaulding, C.M. Boulenc, J.M. Lipiecki, J. Lafont, A. |
2000-06-01
|
|
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
(Article)
Brand, M.J.B.M. van den Laarman, G-J. Steg, P.G. Scheerder, I.K. de Heyndrickx, G.R. Beatt, K.J. Kootstra, J.G. Simoons, M.L. |
1999-11-19
|
|
Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction
(Article)
Dellborg, M. Steg, P.G. Wieken, L.R. van der Hauck, S. Simoons, M.L. Dietz, R. Sen, S. Lotze, U. Himbert, D. Svensson, A.M. Swedberg, K. Brand, M.J.B.M. van den |
1995-01-01
|
